Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySun, 30 Jun 2024 04:35:07 +0200Fri, 07 Jun 2024 11:26:00 +0200Opinion/decision on a Paediatric investigation plan (PIP): Tremfya, Guselkumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastroentology-Hepatology, PIP number: P/0190/2023https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-001523-pip04-19-m02Opinion/decision on a Paediatric investigation plan (PIP): Tremfya, Guselkumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastroentology-Hepatology, PIP number: P/0190/2023https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-001523-pip04-19-m02Fri, 07 Jun 2024 11:26:00 +0200Human medicine